Kalaris Therapeutics KLRS Cash Flow Statement (2019-2026)

NASDAQ KLRS
$4.19 +0.07 (+1.71%)
As of: Aug 21, 2026 · 11:29 AM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-45.51M162.07M-43.86M-44.69M-42.07M-2.88M-45.16M-45.27M-44.27M-205.41M-2.74M-4.69M-38.66M-8.44M-55.02M-14.38M-18.61M-10.80M-16.52M-15.08M
Depreciation and Depletion (Quarter)
0.01M0.01M0.01M
Share-based Compensation (Quarter)
10.29M17.59M10.47M10.95M10.86M-17.56M10.03M10.29M10.47M9.99M0.03M0.32M0.26M0.28M0.37M0.59M0.64M0.41M0.58M0.64M
Change in Interest Receivables (Quarter)
-0.26M-0.10M0.12M-0.08M0.17M-0.10M0.09M-0.14M0.13M-0.03M-0.03M-0.08M-0.04M-0.05M
Cash from Operations (Quarter)
-36.44M-28.07M-46.48M-28.88M-35.13M-31.57M-32.12M-27.12M-34.48M-30.73M-4.50M-4.00M-4.32M-7.88M-7.40M-12.60M-11.31M-7.09M-11.58M-11.03M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.07M-0.08M0.03M0.26M0.87M0.73M0.52M1.23M1.21M0.74M0.38M0.12M0.01M0.32M0.22M0.11M
Amortization of Deferred Charges (Quarter)
0.08M0.50M0.81M1.31M1.44M
Depreciation & Amortization (CF) (Quarter)
0.04M0.09M0.47M0.09M0.09M0.09M0.09M0.09M0.09M0.14M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
-1.24M-0.60M1.70M-0.90M0.93M1.31M-3.20M0.87M-0.38M0.14M
Change in Accured Expenses (Quarter)
2.09M11.48M-13.79M3.42M-0.52M-1.74M-0.49M5.39M-1.86M-5.56M0.07M-0.29M-0.33M0.67M-0.01M0.28M0.15M1.73M0.12M0.75M
Change in Taxes (Quarter)
-0.50M-0.35M-0.03M0.00M-0.00M-0.13M
Other Working Capital Changes (Quarter)
-0.10M-0.04M-0.01M
Investing Activities
Capital Expenditures (Quarter)
0.51M-0.10M-0.12M-0.12M-0.12M-0.12M-0.12M0.19M0.74M0.09M-0.12M0.44M0.10M0.09M-0.17M0.81M-0.01M
Change in Acquisitions & Divestments (Quarter)
55.00M32.60M6.00M31.32M60.00M51.00M53.48M40.33M35.00M35.00M40.00M30.00M20.00M5.00M20.00M20.00M
Cash from Investing Activities (Quarter)
54.97M-13.52M-54.98M-0.48M-38.56M13.54M41.72M37.89M-66.85M25.22M40.00M30.00M20.00M5.00M14.98M-50.35M20.17M
Financing Activities
Other financing activities (Quarter)
0.07M0.29M-69.85M69.85M-0.02M0.00M0.07M0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
4.99M5.00M9.97M7.50M
Change in Capital Stock
Shares Issued (Quarter)
6.72M6.72M6.72M6.72M6.72M6.72M1.14M1.99M2.08M2.14M0.74M2.54M
Net Equity Issued and Repurchased (Quarter)
1.59M
Misc.
Cash from Financing Activities (Quarter)
0.07M126.42M0.29M0.01M6.58M4.98M0.00M7.58M107.27M47.74M-1.70M-0.38M
Exchange Rate Effect (Quarter)
-0.10M
Change in Cash (Quarter)
18.59M-41.53M-101.45M-29.11M52.74M-17.74M9.61M81.26M-101.33M-5.51M2.06M1.01M-4.33M-0.27M99.83M-12.54M-46.04M55.67M-63.63M8.75M
Free Cash Flow (Quarter)
-36.95M-27.96M-46.35M-28.75M-35.01M-31.45M-32.00M-27.32M-35.22M-30.82M-4.38M-4.00M-4.75M-7.98M-7.40M-12.60M-11.40M-6.92M-12.39M-11.01M
Net Cash Flow (Quarter)
18.53M-41.53M-101.45M-29.36M52.74M-17.74M9.61M10.77M-101.33M-5.51M42.08M30.98M15.68M4.70M99.87M-12.60M-11.31M55.64M-63.63M8.77M